{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T02:34:34Z","timestamp":1790476474301,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,25]],"date-time":"2021-11-25T00:00:00Z","timestamp":1637798400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,25]],"date-time":"2021-11-25T00:00:00Z","timestamp":1637798400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Gastrointestinal mucositis is a complication of anticancer treatment, with few validated in vitro systems suitable to study the complex mechanisms of mucosal injury. Therefore, we aimed to develop and characterize a chemotherapeutic-induced model of mucositis using 3D intestinal organoids. Organoids derived from mouse ileum were grown for 7\u00a0days and incubated with different concentrations of the chemotherapeutic agent methotrexate (MTX). Metabolic activity, citrulline levels and cytokine\/chemokine production were measured to determine the optimal dosage and incubation time. The protective effects of folinic acid on the toxicity of MTX were investigated by pre-treating organoids with (0.0005\u201350\u00a0\u00b5g\/mL) folinic acid. The impact of microbial-derived short-chain fatty acids was evaluated by supplementation with butyrate in the organoid model. MTX caused a dose-dependent reduction in cell metabolic activity and citrulline production that was salvaged by folinic acid treatment. Overall, MTX causes significant organoid damage, which can be reversed upon removal of MTX. The protective effect of folinic acid suggest that the organoids respond in a clinical relevant manner. By using the model for intervention, it was found that prophylactic treatment with butyrate might be a valuable strategy for prophylactic mucositis prevention.<\/jats:p>","DOI":"10.1038\/s41598-021-02308-w","type":"journal-article","created":{"date-parts":[[2021,11,25]],"date-time":"2021-11-25T11:08:02Z","timestamp":1637838482000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Development of a self-limiting model of methotrexate-induced mucositis reinforces butyrate as a potential therapy"],"prefix":"10.1038","volume":"11","author":[{"given":"A. R.","family":"da Silva Ferreira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. A. J.","family":"van der Aa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Wehkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. R.","family":"Wardill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. P.","family":"ten Klooster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Garssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. F.","family":"Harthoorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Hartog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. J. M.","family":"Harmsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. J. E.","family":"Tissing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"van Bergenhenegouwen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,25]]},"reference":[{"key":"2308_CR1","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1002\/cncr.20162","volume":"100","author":"ST Sonis","year":"2004","unstructured":"Sonis, S. T. et al. Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 100, 1995\u20132025 (2004).","journal-title":"Cancer"},{"key":"2308_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1053\/j.soncn.2003.10.003","volume":"20","author":"ST Sonis","year":"2004","unstructured":"Sonis, S. T. Pathobiology of mucositis. Semin. Oncol. Nurs. 20, 11\u201315 (2004).","journal-title":"Semin. Oncol. Nurs."},{"key":"2308_CR3","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1097\/CCO.0000000000000180","volume":"27","author":"A Villa","year":"2015","unstructured":"Villa, A. & Sonis, S. T. Mucositis: pathobiology and management. Curr. Opin. Oncol. 27, 159\u2013164 (2015).","journal-title":"Curr. Opin. Oncol."},{"key":"2308_CR4","doi-asserted-by":"crossref","unstructured":"Basile, D. et al. Mucosal injury during anti-cancer treatment: From pathobiology to bedside. Cancers 11, (2019).","DOI":"10.3390\/cancers11060857"},{"key":"2308_CR5","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1177\/1535370215581309","volume":"240","author":"B Vanhoecke","year":"2015","unstructured":"Vanhoecke, B. et al. Dark Agouti rat model of chemotherapy-induced mucositis: Establishment and current state of the art. Exp. Biol. Med. 240, 725\u2013741 (2015).","journal-title":"Exp. Biol. Med."},{"key":"2308_CR6","doi-asserted-by":"publisher","first-page":"3751","DOI":"10.3748\/wjg.v20.i14.3751","volume":"20","author":"CS Lee","year":"2014","unstructured":"Lee, C. S. et al. Gastro-intestinal toxicity of chemotherapeutics in colorectal cancer: The role of inflammation. WJG 20, 3751\u20133761 (2014).","journal-title":"WJG"},{"key":"2308_CR7","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.stem.2009.11.013","volume":"6","author":"N Barker","year":"2010","unstructured":"Barker, N. et al. Lgr5+ve stem cells drive self-renewal in the stomach and build long-lived gastric units in vitro. Cell Stem Cell 6, 25\u201336 (2010).","journal-title":"Cell Stem Cell"},{"key":"2308_CR8","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.celrep.2012.08.018","volume":"2","author":"N Barker","year":"2012","unstructured":"Barker, N. et al. Lgr5+ve stem\/progenitor cells contribute to nephron formation during kidney development. Cell Rep. 2, 540\u2013552 (2012).","journal-title":"Cell Rep."},{"key":"2308_CR9","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1177\/2472555216683651","volume":"22","author":"S Ley","year":"2017","unstructured":"Ley, S. et al. Screening of intestinal crypt organoids: a simple readout for complex biology. SLAS Discov. 22, 571\u2013582 (2017).","journal-title":"SLAS Discov."},{"key":"2308_CR10","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.1038\/emboj.2013.204","volume":"32","author":"M Huch","year":"2013","unstructured":"Huch, M. et al. Unlimited in vitro expansion of adult bi-potent pancreas progenitors through the Lgr5\/R-spondin axis. EMBO J. 32, 2708\u20132721 (2013).","journal-title":"EMBO J."},{"key":"2308_CR11","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/nature07935","volume":"459","author":"T Sato","year":"2009","unstructured":"Sato, T. et al. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature 459, 262\u2013265 (2009).","journal-title":"Nature"},{"key":"2308_CR12","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.cell.2013.07.004","volume":"154","author":"H Clevers","year":"2013","unstructured":"Clevers, H. XThe intestinal crypt, a prototype stem cell compartment. Cell 154, 274 (2013).","journal-title":"Cell"},{"key":"2308_CR13","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.3945\/jn.116.232678","volume":"146","author":"N van der Wielen","year":"2016","unstructured":"van der Wielen, N. et al. The noncaloric sweetener rebaudioside a stimulates glucagon-like peptide 1 release and increases enteroendocrine cell numbers in 2-dimensional mouse organoids derived from different locations of the intestine. J. Nutr. 146, 2429\u20132435 (2016).","journal-title":"J. Nutr."},{"key":"2308_CR14","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/mpo.2950050108","volume":"5","author":"BM Camitta","year":"1978","unstructured":"Camitta, B. M. & Holcenberg, J. S. Safety of delayed leucovorin \u201crescue\u201d following high-dose methotrexate in children. Med. Pediatr. Oncol. 5, 55\u201359 (1978).","journal-title":"Med. Pediatr. Oncol."},{"key":"2308_CR15","doi-asserted-by":"publisher","first-page":"e469","DOI":"10.1111\/jdv.14285","volume":"31","author":"A Randhawa","year":"2017","unstructured":"Randhawa, A., Blair, R. & Wylie, G. Folic acid \u2013 who does what with methotrexate?. J. Eur. Acad. Dermatol. Venereol. 31, e469\u2013e470 (2017).","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"2308_CR16","doi-asserted-by":"crossref","unstructured":"Driehuis, E. et al. Patient-derived oral mucosa organoids as an in vitro model for methotrexate induced toxicity in pediatric acute lymphoblastic leukemia. PLoS One 15, (2020).","DOI":"10.1371\/journal.pone.0237488"},{"key":"2308_CR17","doi-asserted-by":"publisher","unstructured":"Kuiken, N. S. S., Rings, E. H. H. M., Blijlevens, N. M. A. & Tissing, W. J. E. Biomarkers and non-invasive tests for gastrointestinal mucositis. 2933\u20132941 (2017). doi:https:\/\/doi.org\/10.1007\/s00520-017-3752-2","DOI":"10.1007\/s00520-017-3752-2"},{"key":"2308_CR18","doi-asserted-by":"publisher","first-page":"3155","DOI":"10.1182\/blood-2016-12-754994","volume":"129","author":"CEM de Mooij","year":"2017","unstructured":"de Mooij, C. E. M., Netea, M. G., van der Velden, W. J. F. M. & Blijlevens, N. M. A. Targeting the interleukin-1 pathway in patients with hematological disorders. Blood 129, 3155\u20133164 (2017).","journal-title":"Blood"},{"key":"2308_CR19","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1136\/gut.46.3.350","volume":"46","author":"R Daig","year":"2000","unstructured":"Daig, R. et al. Human intestinal epithelial cells secrete interleukin-1 receptor antagonist and interleukin-8 but not interleukin-1 or interleukin-6. Gut 46, 350 (2000).","journal-title":"Gut"},{"key":"2308_CR20","first-page":"241","volume":"5","author":"SE Blutt","year":"2018","unstructured":"Blutt, S. E., Crawford, S. E., Ramani, S., Zou, W. Y. & Estes, M. K. Engineered human gastrointestinal cultures to study the microbiome and infectious diseases. Cmgh 5, 241\u2013251 (2018).","journal-title":"Cmgh"},{"key":"2308_CR21","doi-asserted-by":"crossref","unstructured":"Noel, G. et al. A primary human macrophage-enteroid co-culture model to investigate mucosal gut physiology and host-pathogen interactions. Sci. Rep. 7, (2017).","DOI":"10.1038\/srep45270"},{"key":"2308_CR22","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-019-04893-z","author":"J Bowen","year":"2019","unstructured":"Bowen, J. et al. The pathogenesis of mucositis: updated perspectives and emerging targets. Support. Care Cancer https:\/\/doi.org\/10.1007\/s00520-019-04893-z (2019).","journal-title":"Support. Care Cancer"},{"key":"2308_CR23","doi-asserted-by":"crossref","unstructured":"Kanarek, N. et al. Critical role for IL-1\u03b2 in DNA damageinduced mucositis. Proc. Natl. Acad. Sci. USA 111, (2014).","DOI":"10.1073\/pnas.1322691111"},{"key":"2308_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1748-717X-5-22","volume":"5","author":"ZY Ong","year":"2010","unstructured":"Ong, Z. Y. et al. Pro-inflammatory cytokines play a key role in the development of radiotherapy-induced gastrointestinal mucositis. Radiat. Oncol. 5, 1\u20138 (2010).","journal-title":"Radiat. Oncol."},{"key":"2308_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.29976","author":"EE Bruning","year":"2021","unstructured":"Bruning, E. E., Coller, J. K., Wardill, H. R. & Bowen, J. M. Site-specific contribution of Toll-like receptor 4 to intestinal homeostasis and inflammatory disease. J. Cell. Physiol. https:\/\/doi.org\/10.1002\/jcp.29976 (2021).","journal-title":"J. Cell. Physiol."},{"key":"2308_CR26","doi-asserted-by":"publisher","first-page":"3195","DOI":"10.4049\/jimmunol.168.7.3195","volume":"168","author":"JH Dufour","year":"2002","unstructured":"Dufour, J. H. et al. IFN-\u03b3-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking. J. Immunol. 168, 3195\u20133204 (2002).","journal-title":"J. Immunol."},{"key":"2308_CR27","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.cytogfr.2014.11.009","volume":"26","author":"K Van Raemdonck","year":"2015","unstructured":"Van Raemdonck, K., Van den Steen, P. E., Liekens, S., Van Damme, J. & Struyf, S. CXCR3 ligands in disease and therapy. Cytokine Growth Factor Rev. 26, 311\u2013327 (2015).","journal-title":"Cytokine Growth Factor Rev."},{"key":"2308_CR28","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1136\/jcp.2005.034983","volume":"59","author":"N Ansari","year":"2006","unstructured":"Ansari, N. et al. Comparison of RANTES expression in Crohn\u2019s disease and ulcerative colitis: An aid in the differential diagnosis?. J. Clin. Pathol. 59, 1066\u20131072 (2006).","journal-title":"J. Clin. Pathol."},{"key":"2308_CR29","doi-asserted-by":"publisher","first-page":"552","DOI":"10.4049\/jimmunol.166.1.552","volume":"166","author":"MN Ajuebor","year":"2001","unstructured":"Ajuebor, M. N., Hogaboam, C. M., Kunkel, S. L., Proudfoot, A. E. I. & Wallace, J. L. The chemokine RANTES is a crucial mediator of the progression from acute to chronic colitis in the rat. J. Immunol. 166, 552\u2013558 (2001).","journal-title":"J. Immunol."},{"key":"2308_CR30","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/apt.12878","volume":"40","author":"Y Touchefeu","year":"2014","unstructured":"Touchefeu, Y. et al. Systematic review: the role of the gut microbiota in chemotherapy- or radiation-induced gastrointestinal mucositis current evidence and potential clinical applications. Aliment. Pharmacol. Ther. 40, 409\u2013421 (2014).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"2308_CR31","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1124\/dmd.115.065714","volume":"43","author":"HI Swanson","year":"2015","unstructured":"Swanson, H. I. Special section on drug metabolism and the microbiome commentary drug metabolism by the host and gut microbiota: a partnership or rivalry?. Drug Metab. Dispos. 43, 1499\u20131504 (2015).","journal-title":"Drug Metab. Dispos."},{"key":"2308_CR32","first-page":"1950","volume":"161","author":"SHSP Pedroso","year":"2015","unstructured":"Pedroso, S. H. S. P. et al. Evaluation of mucositis induced by irinotecan after microbial colonization in germ-free mice. Microbiol. (United Kingdom) 161, 1950\u20131960 (2015).","journal-title":"Microbiol. (United Kingdom)"},{"key":"2308_CR33","doi-asserted-by":"publisher","first-page":"430","DOI":"10.3181\/0810-RM-301","volume":"234","author":"AM Stringer","year":"2009","unstructured":"Stringer, A. M. et al. Gastrointestinal microflora and mucins may play a critical role in the development of 5-fluorouracil-induced gastrointestinal mucositis. Exp. Biol. Med. 234, 430\u2013441 (2009).","journal-title":"Exp. Biol. Med."},{"key":"2308_CR34","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1194\/jlr.R036012","volume":"54","author":"G den Besten","year":"2013","unstructured":"den Besten, G. et al. The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J. Lipid Res. 54, 2325\u20132340 (2013).","journal-title":"J. Lipid Res."},{"key":"2308_CR35","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/nature09646","volume":"469","author":"S Fukuda","year":"2011","unstructured":"Fukuda, S. et al. Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature 469, 543\u2013549 (2011).","journal-title":"Nature"},{"key":"2308_CR36","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s11745-012-3680-3","volume":"47","author":"TM Ferreira","year":"2012","unstructured":"Ferreira, T. M. et al. Oral supplementation of butyrate reduces mucositis and intestinal permeability associated with 5-fluorouracil administration. Lipids 47, 669\u2013678 (2012).","journal-title":"Lipids"},{"key":"2308_CR37","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1111\/j.1365-2036.2005.02639.x","volume":"22","author":"A Di Sabatino","year":"2005","unstructured":"Di Sabatino, A. et al. Oral butyrate for mildly to moderately active Crohn\u2019s disease. Aliment. Pharmacol. Ther. 22, 789\u2013794 (2005).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"2308_CR38","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1136\/gut.46.2.218","volume":"46","author":"A Barcelo","year":"2000","unstructured":"Barcelo, A. et al. Mucin secretion is modulated by luminal factors in the isolated vascularly perfused rat colon. Gut 46, 218\u2013224 (2000).","journal-title":"Gut"},{"key":"2308_CR39","doi-asserted-by":"publisher","first-page":"802","DOI":"10.3390\/ph5080802","volume":"5","author":"T Murakami","year":"2012","unstructured":"Murakami, T. & Mori, N. Involvement of multiple transporters-mediated transports in mizoribine and methotrexate pharmacokinetics. Pharmaceuticals 5, 802\u2013836 (2012).","journal-title":"Pharmaceuticals"},{"key":"2308_CR40","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.3899\/jrheum.111593","volume":"39","author":"MCFJ De Rotte","year":"2012","unstructured":"De Rotte, M. C. F. J. et al. ABCB1 and ABCC3 gene polymorphisms are associated with first-year response to methotrexate in juvenile idiopathic arthritis. J. Rheumatol. 39, 2032\u20132040 (2012).","journal-title":"J. Rheumatol."},{"key":"2308_CR41","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1586\/erm.10.36","volume":"10","author":"ZB Nagy","year":"2010","unstructured":"Nagy, Z. B. et al. Current concepts in the genetic diagnostics of rheumatoid arthritis. Expert Rev. Mol. Diagn. 10, 603\u2013618 (2010).","journal-title":"Expert Rev. Mol. Diagn."},{"key":"2308_CR42","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1097\/00001813-200503000-00004","volume":"16","author":"C Massart","year":"2005","unstructured":"Massart, C., Poirier, C., Fergelot, P., Fardel, O. & Gibassier, J. Effect of sodium butyrate on doxorubicin resistance and expression of multidrug resistance genes in thyroid carcinoma cells. Anticancer. Drugs 16, 255\u2013261 (2005).","journal-title":"Anticancer. Drugs"},{"key":"2308_CR43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.ppat.1000879","volume":"6","author":"MJ van Vliet","year":"2010","unstructured":"van Vliet, M. J., Harmsen, H. J. M., de Bont, E. S. J. M. & Tissing, W. J. E. The role of intestinal microbiota in the development and severity of chemotherapy-induced mucositis. PLoS Pathog. 6, 1\u20137 (2010).","journal-title":"PLoS Pathog."},{"key":"2308_CR44","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1007\/s00520-014-2487-6","volume":"23","author":"M Fijlstra","year":"2015","unstructured":"Fijlstra, M. et al. Substantial decreases in the number and diversity of microbiota during chemotherapy-induced gastrointestinal mucositis in a rat model. Support. Care Cancer 23, 1513\u20131522 (2015).","journal-title":"Support. Care Cancer"},{"key":"2308_CR45","doi-asserted-by":"crossref","unstructured":"Gaies, E. & Jebabli, N. Methotrexate Side Effects: Review Article. J. Drug Metab. Toxicol. 3, (2012).","DOI":"10.4172\/2157-7609.1000125"},{"key":"2308_CR46","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1038\/nm.3737","volume":"20","author":"CL Watson","year":"2014","unstructured":"Watson, C. L. et al. An in vivo model of human small intestine using pluripotent stem cells. Nat. Med. 20, 1310\u20131314 (2014).","journal-title":"Nat. Med."},{"key":"2308_CR47","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1096\/fj.201700504r","volume":"32","author":"KB Jung","year":"2018","unstructured":"Jung, K. B. et al. In vitro and in vivo imaging and tracking of intestinal organoids from human induced pluripotent stem cells. FASEB J. 32, 111\u2013122 (2018).","journal-title":"FASEB J."},{"key":"2308_CR48","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nmeth.2737","volume":"11","author":"X Yin","year":"2014","unstructured":"Yin, X. et al. Niche-independent high-purity cultures of Lgr5 + intestinal stem cells and their progeny. Nat. Methods 11, 106\u2013112 (2014).","journal-title":"Nat. Methods"},{"key":"2308_CR49","doi-asserted-by":"crossref","unstructured":"Demacker, P. N. M. et al. Plasma citrulline measurement using UPLC tandem mass-spectrometry to determine small intestinal enterocyte pathology. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 877, 387\u2013392 (2009).","DOI":"10.1016\/j.jchromb.2008.12.041"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-02308-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-02308-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-02308-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T03:29:28Z","timestamp":1699846168000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-02308-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,25]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["2308"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-02308-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,25]]},"assertion":[{"value":"29 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22911"}}